索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]谷梦 魏丹 陈文 董宁征.急性心肌梗死新型标志物的研究进展[J].国际心血管病杂志,2018,05:263-265.
点击复制

急性心肌梗死新型标志物的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2018年05期
页码:
263-265
栏目:
综述
出版日期:
2019-02-01

文章信息/Info

Title:
-
作者:
谷梦 魏丹 陈文 董宁征
Author(s):
-
关键词:
急性心肌梗死;  标志物;  微小RNA;  Corin;  和肽素
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2018.05.002
文献标识码:
-
摘要:
急性心肌梗死的早期诊断对疾病的控制及预后改善至关重要。新型生物标志物的研发有助于急性心肌梗死的早期诊断。该文介绍了近年来急性心肌梗死的新型标志物,包括微小RNA、和肽素、Corin及正五聚蛋白3等的研究进展
Abstract:
-

参考文献/References


[1] 柯元南, 陈纪林. 不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J]. 中华心血管病杂志, 2007, 35(4):295-304.
[2] Conrad MJ, Jarolim P. Cardiac troponins and high-sensitivity cardiac troponin assays[J]. Clin Lab Med, 2014, 34(1):59-73.
[3] Gerhardt W, Nordin G, Ljungdahl L. Can troponin T replace CK MB mass as "gold standard" for acute myocardial infarction("AMI")?[J]. Scand J Clin Lab Invest Suppl, 1999, 230:83-89.
[4] Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse[J]. Curr Biol, 2002, 12(9):735-739.
[5] Creemers EE, Tijsen AJ, Pinto YM. Circulating MicroRNAs novel biomarkers and extracellular communicators in cardiovascular disease?[J]. Circ Res, 2012, 110(3):483-495.
[6] Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction[J]. Clin Sci(Lond), 2010, 119(2):87-95.
[7] D'Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction[J]. Eur Heart J, 2010, 31(22):2765-2773.
[8] Liebetrau C, Möllmann H, Dörr O, et al. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy[J]. J Am Coll Cardiol, 2013, 62(11):992-998.
[9] Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA:a novel potential biomarker for early diagnosis of acute myocardial infarction in humans[J]. Eur Heart J, 2010, 31(6):659-666.
[10] Zhang L, Chen X, Su T, et al. Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction[J]. J Thorac Dis, 2015, 7(3):303-308.
[11] Yang SY, Wang YQ, Gao HM, et al. The clinical value of circulating miR-99a in plasma of patients with acute myocardial infarction[J]. Eur Rev Med Pharmacol Sci, 2016, 20(24):5193-5197.
[12] Guo ML, Guo LL, Weng YQ. Implication of peripheral blood miRNA-124 in predicting acute myocardial infarction[J]. Eur Rev Med Pharmacol Sci, 2017, 21(5):1054-1059.
[13] Eryilmaz U, Akgüllü Ç, Be �瘙 塂 er N, et al. Circulating microRNAs in patients with ST-elevation myocardial infarction[J]. Anatol J Cardiol, 2016, 16(6):392-396.
[14] Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction[J]. J Am Coll Cardiol, 2010, 55(19):2096-2106.
[15] Ray P, Charpentier S, Chenevier-Gobeaux C, et al. Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease[J]. Am J Emerg Med, 2012, 30(3):440-448.
[16] Mueller C, Möckel M, Giannitsis E, et al. Use of copeptin for rapid rule-out of acute myocardial infarction[J]. Eur Heart J Acute Cardiovasc Care, 2017, Jun 1. [Epub ahead of print].
[17] Li H, Zhang Y, Wu Q. Role of corin in the regulation of blood pressure[J]. Curr Opin Nephrol Hypertens, 2017, 26(2):67-73.
[18] Jiang J, Wu S, Wang W, et al. Ectodomain shedding and autocleavage of the cardiac membrane protease corin[J]. J Biol Chem, 2011, 286(12):10066-10072.
[19] Peleg A, Ghanim D, Vered S, et al. Serum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndrome[J]. Eur Heart J Acute Cardiovasc Care, 2013, 2(2):159-165.
[20] Zhou X, Chen J, Zhang Q, et al. Prognostic value of plasma soluble corin in patients with acute myocardial infarction[J]. J Am Coll Cardiol, 2016, 67(17):2008-2014.
[21] Zhang SM, Shen JX, Li H, et al. Association between serum corin levels and risk of acute myocardial infarction[J]. Clin Chim Acta, 2016, 452:134-137.
[22] Wolf D, Stachon P, Bode C, et al. Inflammatory mechanisms in atherosclerosis[J]. Hamostaseologie, 2014, 34(1):63-71.
[23] Akgul O, Baycan OF, Bulut U, et al. Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction[J]. Coron Artery Dis, 2015, 26(7):592-597.
[24] Tomandlova M, Jarkovsky J, Tomandl J, et al. Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress[J]. Dis Markers, 2015, 2015:159051.
[25] Peri G, Introna M, Corradi D, et al. PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans[J]. Circulation, 2000, 102(6):636-641.
[26] Fornai F, Carrizzo A, Forte M, et al. The inflammatory protein Pentraxin 3 in cardiovascular disease[J]. Immun Ageing, 2016, 13(1):25.
[27] Ustündagˇ M, Orak M, Gülogˇlu C, et al. Comparative diagnostic accuracy of serum levels of neutrophil activating peptide-2 and pentraxin-3 versus troponin-Ⅰ in acute coronary syndrome[J]. Anadolu Kardiyol Derg, 2011, 11(7):588-594.
[28] Latini R, Maggioni AP, Peri G, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction[J]. Circulation, 2004, 110(16):2349-2354.
[29] Ketter P, Yu JJ, Cap AP, et al. Pentraxin 3:an immune modulator of infection and useful marker for disease severity assessment in sepsis[J]. Expert Rev Clin Immunol, 2016, 12(5):501-507.
[30] Garg P, Morris P, Fazlanie AL, et al. Cardiac biomarkers of acute coronary syndrome:from history to high-sensitivity cardiac troponin[J]. Intern Emerg Med, 2017, 12(2):147-155.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81570457)
作者单位:215123 苏州大学唐仲英血液研究中心
通信作者:董宁征,Email:ningzhengdong@suda.edu.cn
更新日期/Last Update: 2018-09-30